DOI: 10.1007/s00259-017-3648-xPages: 1-3
Monitoring metastatic lesions in TENIS, initiating multi-targeted tyrosine kinase inhibitors and follow-up: should the newer FDG PET-CT quantitative indices be the defining objective parameter in clinical trials?
1. Tata Memorial Centre Annexe, Radiation Medicine Centre, Bhabha Atomic Research Centre
To access the full text, please Sign in
If you have institutional access, please click here